SAR443579
Sanofi
['leusm', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)']
congress | #eha2023 | poster presents preliminary safety and efficacy data of sar443579 from a phase i/ii trial in patients with r/r aml. sar443579 was well tolerated up to doses of 3000 g/kg qw, with clinical benefit in patients with r/r aml. #leusm 
The AML Hub is an evidence-based online resource on Acute Myeloid Leukemia (AML), for academic researchers and treating clinicians. #leusm